CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Bayer Intellectual Property GmbH v. Mylan Pharmaceuticals Inc.

1:17-cv-00584

Overview

Case Number 1:17-cv-00584
Filing Date 2017-05-19
Status Terminated
Termination Date 2020-09-02
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Mylan Pharmaceuticals Inc. Operating Company

Represented By

6 Attorneys Listed

Kristina M. Hanson

Email: thanson@wsgr.com

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Elham F. Steiner

Email: esteiner@wsgr.com

David M. Hanna

Email: dhanna@proskauer.com

Douglas H. Carsten

Email: dcarsten@mwe.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Bayer AG NPE (Individual / Inventor)

Represented By

3 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Janssen Pharmaceuticals, Inc. Operating Company

Represented By

3 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Plaintiff

Bayer Intellectual Property GmbH Operating Company

Represented By

3 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇪🇺 Europe 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (2 found):
PTAB: 1 U.S. Courts: 1
USPTO PTAB Trial 2018-05-24
IPR2018-01143

Mylan Pharmaceuticals Inc. et al. v. Bayer Intellectual Property GmbH et al.

Asserted Patent
Status: Institution Denied
U.S. District Court 2017-05-12
1:17-cv-00560

Bayer Intellectual Property GmbH v. Micro Labs Ltd.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9539218
Prevention and treatment of thromboembolic disorders
Filed: 2006-01-19
Issued: 2017-01-10
Active (7.2 yrs remaining) +2951d PTA
Expires: 2034-02-17

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+2951 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/9/2018. Amended Pleadings due by 3/9/2018....
Entry #18 • 2017-10-02 Document →

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2144634.) - filed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jcs) (Entered: 05/19/2017)

Entry #1 • 2017-05-19
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 05/19/2017)

Entry #2 • 2017-05-19
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/7/2017. Date of Expiration of Patent: 2/17/2034.Thirty Month Stay Deadline: 1/1/2019. (jcs) (Entered: 05/19/2017)

Entry #3 • 2017-05-19
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (jcs) (Entered: 05/19/2017)

Entry #4 • 2017-05-19
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GmbH filed by Bayer AG, Bayer Intellectual Property GmbH. (jcs) (Entered: 05/19/2017)

Entry #5 • 2017-05-19
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc